These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37993101)

  • 1. Clinical Risk Factors for Placenta Accreta or Placenta Percreta: A Case-Control Study.
    Noël I; Ghesquiere L; Guerby P; Maheux-Lacroix S; Bujold E; Moretti F
    J Obstet Gynaecol Can; 2024 Apr; 46(4):102294. PubMed ID: 37993101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.
    Lucidi A; Jauniaux E; Hussein AM; Coutinho CM; Tinari S; Khalil A; Shamshirsaz A; Palacios-Jaraquemada JM; D'Antonio F
    Ultrasound Obstet Gynecol; 2023 Nov; 62(5):633-643. PubMed ID: 37401769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 7. Etiopathogenesis and risk factors for placental accreta spectrum disorders.
    Ali H; Chandraharan E
    Best Pract Res Clin Obstet Gynaecol; 2021 Apr; 72():4-12. PubMed ID: 32753310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Gynecol Oncol; 2022 Sep; 166(3):460-464. PubMed ID: 35781164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study.
    El Gelany S; Mosbeh MH; Ibrahim EM; Mohammed M; Khalifa EM; Abdelhakium AK; Yousef AM; Hassan H; Goma K; Alghany AA; Mohammed HF; Azmy AM; Ali WA; Abdelraheim AR
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):313. PubMed ID: 31455286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta.
    De Mucio B; Serruya S; Alemán A; Castellano G; Sosa CG
    Int J Gynaecol Obstet; 2019 Dec; 147(3):281-291. PubMed ID: 31469907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 12 cases of spontaneous uterine rupture caused by placenta percreta].
    Li XF; Wu J; Zhou Y; Zhao XL
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):691-696. PubMed ID: 33120481
    [No Abstract]   [Full Text] [Related]  

  • 13. Utilizations and outcomes of intra-arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum.
    Matsuo K; Matsuzaki S; Vestal NL; Sangara RN; Mandelbaum RS; Matsushima K; Klar M; Ouzounian JG
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2234-2243. PubMed ID: 34622939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Reported Health Outcomes and Quality of Life after Peripartum Hysterectomy for Placenta Accreta Spectrum.
    Grover B; Einerson BD; Keenan KD; Gibbins KJ; Callaway E; Lopez S; Silver RM
    Am J Perinatol; 2022 Feb; 39(3):281-287. PubMed ID: 32819016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta.
    di Pasquo E; Ghi T; Calì G; D'Antonio F; Fratelli N; Forlani F; Prefumo F; Kaihura CT; Volpe N; Dall'Asta A; Frusca T
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):460-466. PubMed ID: 31503353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.
    Marcellin L; Delorme P; Bonnet MP; Grange G; Kayem G; Tsatsaris V; Goffinet F
    Am J Obstet Gynecol; 2018 Aug; 219(2):193.e1-193.e9. PubMed ID: 29733839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for bladder injury during placenta accreta spectrum surgery.
    Friedrich L; Mor N; Weissmann-Brenner A; Kassif E; Friedrich SN; Weissbach T; Castel E; Levin G; Meyer R
    Int J Gynaecol Obstet; 2023 Jun; 161(3):911-919. PubMed ID: 36353748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study.
    Schwickert A; van Beekhuizen HJ; Bertholdt C; Fox KA; Kayem G; Morel O; Rijken MJ; Stefanovic V; Strindfors G; Weichert A; Weizsaecker K; Braun T;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():29-40. PubMed ID: 33524163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between maternal obesity and placenta accreta spectrum: A multinational database study.
    Vieira MC; Rijken MJ; Braun T; Chantraine F; Morel O; Schwickert A; Stefanovic V; van Beekhuizen H; Collins SL;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():50-57. PubMed ID: 33811335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placenta Accreta Spectrum (PAS): Diagnosis, Clinical Presentation, Therapeutic Approaches, and Clinical Outcomes.
    Markfeld Erol F; Häußler JA; Medl M; Juhasz-Boess I; Kunze M
    Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.